Triglyceride to HDL ratio = triglycerides (mg/dL) ÷ HDL cholesterol (mg/dL).
The best known cut-off comes from the Stanford study cited on this page. In 258 overweight adults without diabetes, a ratio of 3.0 or higher, with both values in mg/dL, was one of the better simple markers of insulin resistance. It caught 64% of the insulin resistant group and correctly cleared 68% of the rest.
Those figures mean the ratio is a screening clue, not a verdict. Some people above 3.0 turn out not to be insulin resistant on more direct testing, and some people below it are. A result above 3.0 is a reason to look at fasting glucose, insulin and A1c with a clinician.
It also helps to read the two inputs on their own. The ATP III report treats fasting triglycerides below 150 mg/dL as normal, 150 to 199 as borderline high, 200 to 499 as high and 500 or above as very high. It treats HDL below 40 mg/dL as low.
Triglycerides are the more changeable of the two inputs. They rise for hours after a meal, especially one rich in refined carbohydrate or fat, and alcohol in the previous day or two can push them up. A fasting sample removes most of that noise, which is why the research used fasting panels.
Over weeks to months, excess body weight, physical inactivity and poorly controlled blood sugar tend to raise triglycerides and lower HDL at the same time, which moves the ratio up from both ends. Weight loss and regular activity tend to do the reverse.
The ATP III report lists conditions and medicines that can shift these values. An underactive thyroid, some kidney conditions and diabetes can raise triglycerides. Oral estrogens, corticosteroids, retinoids and beta blockers can raise triglycerides or lower HDL, and anabolic steroids and progestins can lower HDL.
If the panel was not fasting, a high ratio is worth repeating on a fasting sample before reading much into it, because a recent meal can lift triglycerides on its own. Try to keep the repeat under similar conditions, without heavy drinking or an unusual meal the night before.
Because the ratio responds to weight, activity and diet over weeks to months, rechecking after a few months of steady change gives a clearer signal than rechecking within days. Tracking the trend across several panels is more useful than any single value. When a clinician has already asked for a recheck on a set schedule, that schedule comes first, and it helps to bring earlier panels so the values can be compared side by side.
Triglycerides of 500 mg/dL or more, the ATP III very high band, are worth raising with a clinician promptly whatever the ratio shows. So is a high ratio alongside symptoms such as unusual thirst or frequent urination, which can go with high blood sugar.
The 3.0 cut-off was set in overweight adults at one center, and does not transfer cleanly to every group. A 2005 study by Sumner and colleagues found fasting triglycerides and the triglyceride to HDL ratio were poor markers of insulin resistance in African American adults, who often have normal triglycerides despite insulin resistance.
The cut-off also only applies to values in mg/dL. In mmol/L the same blood gives a much smaller ratio, because triglycerides and HDL convert by different factors. Comparing a mmol/L ratio with 3.0 will mislead. If your lab reports in mmol/L, convert both values to mg/dL first or compare only with earlier ratios worked out in the same units. This calculator expects mg/dL for both inputs.
Finally, the ratio is indirect. It reflects a pattern of lipids that often travels with insulin resistance, rather than measuring insulin action itself. Fasting insulin, HOMA-IR and other direct tests measure that more closely, and a clinician can choose among them.
Take fasting triglycerides of 165 mg/dL and HDL of 42 mg/dL from the same draw. The formula is triglycerides divided by HDL, so 165 divided by 42 gives 3.9286, which the calculator shows as 3.93. Both values in mg/dL is what makes the result comparable with the study cut-off. The person here fasted overnight, matching the conditions the research used.
That sits above the 3.0 cut-off from the Stanford study. In that study's terms it is a clue that the body may need more insulin to manage glucose, though the test missed about a third of insulin resistant people and flagged about a third of those who were not.
Looking at the inputs, 165 mg/dL triglycerides falls in the ATP III borderline high band and 42 mg/dL HDL is just above the low cut-off of 40. A sensible next step is reading fasting glucose, fasting insulin and A1c with a clinician. If the same person's triglycerides fell to 120 with HDL unchanged, 120 divided by 42 gives 2.86, under the cut-off.
The Stanford study tested the ratio next to fasting triglycerides alone and fasting insulin. All three performed in a similar range as markers of insulin resistance, and none was accurate enough to replace direct testing. The ratio's advantage is that it comes free with a standard lipid panel.
The ratio is also read as a heart risk marker. A 1997 Boston case-control study by Gaziano and colleagues found the triglyceride to HDL ratio was a strong predictor of heart attack, standing out among the lipid measures they compared.
HOMA-IR, which uses fasting insulin and glucose, measures insulin resistance more directly but needs an insulin test. The total cholesterol to HDL ratio and non-HDL cholesterol speak more to cholesterol carried in particles linked with plaque. A clinician often reads several of these side by side rather than picking one.
The Heart health panel measures the values this calculator uses. Related: triglycerides, hdl cholesterol, homa ir.
A triglyceride to HDL ratio calculator divides your fasting triglyceride result by your HDL cholesterol result, with both values in the same units. The calculator above does that arithmetic for you. The output is a single number used widely in research as a metabolic signal, and a higher ratio is associated with insulin resistance in adults 1. It is a clue, not a diagnosis.
This page explains where the two inputs come from, how to read the output, and the things that quietly shift it, including whether your lab reports lipids in mg/dL or mmol/L. This article is educational and is not medical advice.
It uses two values that already appear on a standard lipid panel, and nothing else. Triglycerides are the circulating fats your body packages after meals and releases from storage between them. HDL cholesterol is the cholesterol carried on high-density lipoprotein particles. The calculator takes the first number, divides it by the second, and returns the quotient.
If your panel reports triglycerides of 120 mg/dL and HDL cholesterol of 50 mg/dL, the ratio is 120 divided by 50, which is 2.4. If triglycerides are 180 mg/dL and HDL is 40 mg/dL, the ratio is 4.5. Nothing is weighted, adjusted for age, or corrected for sex. That simplicity is the point. The ratio is designed to be computable from results you already have, with no extra blood draw and no specialised assay.
Most laboratories do not print this ratio on the report, because it is a derived value rather than a measured one. That is why calculators exist. Two practical notes before you type anything in. First, use results from the same blood draw, since triglycerides and HDL drawn weeks apart describe two different days of physiology. Second, check the units printed next to each result, because the same biology produces a very different looking number depending on how your lab reports it.
The honest answer is that a lower ratio generally sits alongside a more favourable metabolic picture, and a higher one is a prompt to look further, not a verdict. There is no single internationally agreed diagnostic cut-off, and the thresholds used in published work differ by population, sex and ancestry.
In mg/dL units, a result above about 3 is the zone most often flagged. Observation, triglycerides are high relative to HDL. What it may reflect, insulin resistance, since research suggests that the triglyceride to HDL ratio performs as a surrogate marker of insulin resistance in adult populations 1. The ratio is associated with metabolic syndrome and with severe atherosclerosis in observational work 2. Next step, this is worth discussing with a clinician alongside your full lipid panel and glucose markers, rather than treated as a standalone finding.
Two caveats keep this from being a scoreboard. The relationship with outcomes is not a straight line. Research suggests that, in a large cohort of middle-aged and older adults, the association between the triglyceride to HDL cholesterol ratio and long-term heart disease risk is nonlinear 3, meaning the same one-point increase does not carry the same weight everywhere along the scale. And a high ratio is a pattern, not a diagnosis. Only a clinician reviewing your history, your examination and your complete results can say what it means for you.
Four things move this ratio without anything changing in your long-term metabolic health.
Units. This is the single biggest source of confusion. Triglycerides and HDL cholesterol convert between units using different factors, so the ratio itself is unit-dependent. Triglycerides in mmol/L multiply by about 88.6 to reach mg/dL. HDL cholesterol in mmol/L multiplies by about 38.7. The net effect is that a ratio calculated in mmol/L is roughly 2.3 times smaller than the same person's ratio calculated in mg/dL. A result of 3.5 in mg/dL units is about 1.5 in mmol/L units. If you compare your number against a threshold you read somewhere, confirm which unit system that threshold assumed. The calculator on this page expects mg/dL.
Fasting status and recent meals. Triglycerides are the volatile half of this equation. They rise after eating, particularly after a meal rich in fat or refined carbohydrate, and can stay elevated for hours. Alcohol the evening before a draw raises them too. HDL cholesterol moves far more slowly. So a non-fasted sample inflates the numerator while leaving the denominator roughly where it was, which inflates the ratio. A fasted morning draw, taken under conditions similar to any previous test you want to compare it against, gives you the most interpretable number.
Who you are. The ratio does not behave identically in everyone. Studies suggest that its usefulness as a predictor of insulin resistance and beta-cell function differs between ancestry groups, performing better in some populations than others 4. Sex, body composition and medication use all shift typical values. Pregnancy changes lipid physiology substantially, and a meta-analysis found that the triglyceride to HDL cholesterol ratio is associated with pregnancy-related risks 5, which is a reminder that pregnancy ranges are their own topic and are not comparable to general adult reference points. Chronic kidney disease is another special case, and a systematic review examined the ratio's value as a predictor of mortality and cardiovascular disease in people receiving haemodialysis, where the evidence is more mixed than in the general population 6.
Ordinary biological variation. Any single lipid panel is one sample of a moving target. Acute illness, inflammation, a recent hard training session, significant weight change and sleep debt all nudge triglycerides. Two draws a fortnight apart in the same person can differ meaningfully. A trend across several tests tells you far more than one number ever will.
On its own, the ratio is a screening signal. Its value comes from what it sits next to. The biomarker page for the Triglyceride/HDL Ratio covers the marker in more depth, and the table below shows the companions that usually change how it is interpreted.
| Marker | What it measures | Why it belongs next to the ratio |
|---|---|---|
| Fasting glucose | Blood sugar after an overnight fast | A direct read on glycaemic status that the ratio only infers |
| Fasting insulin | How much insulin is needed to hold that glucose | Often rises before glucose does, so it can move earlier |
| HbA1c | Average glycaemia over roughly the past three months | Smooths out single-day noise in blood sugar |
| ApoB | The number of atherogenic lipoprotein particles | Counts particles rather than describing a metabolic pattern |
| LDL cholesterol | Cholesterol carried on LDL particles | The established lipid target most treatment decisions are built around |
| Non-HDL cholesterol | All cholesterol outside HDL particles | Captures triglyceride-rich remnants that LDL alone misses |
| hs-CRP | Low-grade systemic inflammation | Adds context when metabolic markers are drifting |
The ratio has been compared directly against other calculated indices of insulin resistance. One study compared the triglyceride glucose index, the triglyceride to HDL cholesterol ratio and the metabolic score for insulin resistance in adults, finding that these surrogate indices do not always behave identically against the same outcome 7. In other words, no single calculated index is the answer, and measured markers remain the anchor.
No. It answers a different question, and treating it as a replacement is the most common mistake people make with it.
LDL cholesterol and ApoB describe the atherogenic particle burden in your circulation, which is the quantity that cardiovascular treatment decisions are generally built around. ApoB is the more direct of the two, because each atherogenic particle carries exactly one ApoB molecule, so the measurement counts particles rather than estimating the cholesterol inside them. Someone can have a comfortable LDL number and a higher particle count, which is exactly why ApoB has become so useful.
The triglyceride to HDL ratio describes something else, the metabolic environment those particles are moving through. High triglycerides with low HDL is the classic pattern of insulin resistance, and it tends to travel with smaller, denser LDL particles even when the LDL cholesterol number itself looks unremarkable. That is why the ratio has been described as a clue to metabolic syndrome, insulin resistance and severe atherosclerosis 2, and why research in high-risk patients has linked an elevated ratio to long-term mortality 8.
Read together, they cover more ground than either does alone. A normal ApoB with a high ratio points towards metabolic work. A normal ratio with a high ApoB points towards lipid work. Both elevated is a conversation to have with a clinician sooner rather than later. What happens next, including whether any treatment is appropriate, is a decision a licensed provider makes after reviewing your complete picture.
The two values this calculator needs come from a standard lipid panel, which is included in the Heart Health panel from FitScript along with ApoB, lipoprotein(a) and the other cardiovascular markers that give the ratio its context. Because the membership covers 150+ biomarkers tested per year, the glucose and insulin markers that sit alongside the ratio are measured in the same window rather than months apart, which is what makes a trend readable.
Results are interpreted by Atlas, FitScript's AI health advisor, which explains what each value shows and how the markers relate to one another. Any treatment decision that follows is made by a licensed provider who evaluates whether it is appropriate for you.
Take your results to a clinician if the ratio sits in the higher band on a properly fasted draw, if it has been climbing across several tests, or if it is elevated alongside rising fasting glucose, fasting insulin or HbA1c. The same applies if ApoB or non-HDL cholesterol is outside the standard range at the same time, or if you have a family history of early cardiovascular disease or type 2 diabetes.
A markedly elevated triglyceride level on its own, regardless of what the ratio works out to, is worth discussing with a clinician promptly, since very high triglycerides carry their own considerations beyond cardiovascular risk. Never ignore a result that falls outside your laboratory's reference range because a calculated ratio looks acceptable.
Bring the actual report rather than the ratio alone, including the units, the fasting status and the date. Discuss your results and any treatment with a clinician or licensed provider, who can weigh them against your history in a way no calculator can.
Research in overweight adults used 3.0 as the cut-off for insulin resistance. FitScript shows its own optimal range next to your result.
The study used fasting samples, and triglycerides rise after meals, so a fasting panel matches the research best.
No. It identified insulin resistance in about two thirds of cases in the study, so it is a clue a clinician reads with other tests.
Divide your triglyceride value by your HDL cholesterol value, using results from the same blood draw and the same units. Triglycerides of 150 mg/dL with HDL of 50 mg/dL gives a ratio of 3.0. No adjustment is made for age, sex or weight, which is part of why the number should be read alongside the rest of your panel rather than on its own.
Yes, and this trips up more people than anything else. Triglycerides and HDL cholesterol convert between units using different factors, so a ratio calculated in mmol/L comes out roughly 2.3 times smaller than the same person's ratio in mg/dL. A number that looks reassuring in one unit system can be well above the usual thresholds in the other. Always check which units a published threshold assumes.
A fasted morning draw gives the most interpretable ratio. Triglycerides rise after eating and can stay elevated for hours, while HDL cholesterol moves far more slowly, so a non-fasted sample tends to inflate the ratio without reflecting any real change in your metabolism. Alcohol the night before has a similar effect. If you want to compare results over time, keep the conditions consistent between draws.
No. The ratio is a surrogate marker, not a diagnostic test. It may help as a screening signal for insulin resistance in adults, but confirming anything requires direct markers such as fasting glucose, fasting insulin and HbA1c, interpreted together by a clinician who knows your history. A single calculated number never establishes a condition.
It is not more important, it is different. LDL cholesterol and ApoB describe the atherogenic particle burden in your blood, which is what most cardiovascular treatment decisions are built around. The ratio describes the metabolic pattern those particles sit within. Reading them together tells you more than either alone, which is why a full lipid panel is the starting point.
Yes. Pregnancy changes lipid physiology substantially, chronic kidney disease alters how the ratio behaves, and acute illness, inflammation or significant recent weight change can all shift triglycerides. Published work also suggests the ratio predicts insulin resistance better in some ancestry groups than others. These are reasons to interpret it with a clinician rather than against a generic threshold.
Because it is derived from a standard lipid panel, it updates whenever your lipids are retested. A trend across several panels is far more informative than a single value, since ordinary day-to-day variation can move triglycerides meaningfully between draws. Your clinician can advise on a sensible retesting interval based on your results and risk profile.
Confirm it on a properly fasted sample, then take the full report, including units and fasting status, to a clinician. Bring your glucose, insulin, HbA1c and ApoB results from the same window if you have them. A higher ratio is a prompt for a fuller look at your metabolic and cardiovascular picture, and any decision about treatment belongs to a licensed provider who has evaluated you.